- Filed
- Nov 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Nov 11, 2025 | 697M sh |
| Shares Diluted | Q1 2026 · Oct 31, 2025 | 709M sh |
| Shares Diluted restated | Q1 2026 · Oct 31, 2024 | 709M sh |
| Operating Cash Flow | Q1 2026 · Oct 31, 2025 | $1.77B |
| Operating Cash Flow restated | Q1 2026 · Oct 31, 2024 | $1.51B |
| Short Term Investments | Q1 2026 · Oct 31, 2025 | $1.14B |
| Short Term Investments | Q1 2026 · Jul 31, 2025 | $635M |
| Cash And Equivalents | Q1 2026 · Oct 31, 2025 | $3.07B |
| Cash And Equivalents | Q1 2026 · Jul 31, 2025 | $2.27B |
| Cash And Equivalents restated | Q1 2026 · Oct 31, 2024 | $2.28B |
| Stockholders Equity | Q1 2026 · Oct 31, 2025 | $8.67B |
| Stockholders Equity | Q1 2026 · Jul 31, 2025 | $7.82B |
| Stockholders Equity restated | Q1 2026 · Oct 31, 2024 | $5.91B |
| Stockholders Equity restated | Q1 2026 · Jul 31, 2024 | $5.17B |
| Current Liabilities | Q1 2026 · Oct 31, 2025 | $7.42B |
| Current Liabilities | Q1 2026 · Jul 31, 2025 | $7.99B |
| Total Liabilities | Q1 2026 · Oct 31, 2025 | $14.87B |
| Total Liabilities | Q1 2026 · Jul 31, 2025 | $15.75B |
| Current Assets | Q1 2026 · Oct 31, 2025 | $7.31B |
| Current Assets | Q1 2026 · Jul 31, 2025 | $7.52B |
| Total Assets | Q1 2026 · Oct 31, 2025 | $23.54B |
| Total Assets | Q1 2026 · Jul 31, 2025 | $23.58B |
| Eps Diluted | Q1 2026 · Oct 31, 2025 | $0.47 |
| Eps Diluted restated | Q1 2026 · Oct 31, 2024 | $0.49 |
| Eps Basic | Q1 2026 · Oct 31, 2025 | $0.49 |
| Eps Basic restated | Q1 2026 · Oct 31, 2024 | $0.54 |
| Sga Expense | Q1 2026 · Oct 31, 2025 | $179M |
| Sga Expense restated | Q1 2026 · Oct 31, 2024 | $98M |
| Rd Expense | Q1 2026 · Oct 31, 2025 | $528M |
| Rd Expense restated | Q1 2026 · Oct 31, 2024 | $481M |
| Net Income | Q1 2026 · Oct 31, 2025 | $334M |
| Net Income restated | Q1 2026 · Oct 31, 2024 | $351M |
| Operating Income | Q1 2026 · Oct 31, 2025 | $309M |
| Operating Income restated | Q1 2026 · Oct 31, 2024 | $286M |
| Gross Profit | Q1 2026 · Oct 31, 2025 | $1.84B |
| Gross Profit restated | Q1 2026 · Oct 31, 2024 | $1.59B |
| Cost Of Revenue | Q1 2026 · Oct 31, 2025 | $638M |
| Cost Of Revenue restated | Q1 2026 · Oct 31, 2024 | $554M |
| Revenue | Q1 2026 · Oct 31, 2025 | $2.47B |
| Revenue restated | Q1 2026 · Oct 31, 2024 | $2.14B |